Research Analysts Offer Predictions for Palomar Q4 Earnings

Palomar Holdings, Inc. (NASDAQ:PLMRFree Report) – Investment analysts at Zacks Research boosted their Q4 2026 earnings estimates for shares of Palomar in a research report issued to clients and investors on Friday, June 19th. Zacks Research analyst Team now expects that the company will post earnings of $2.53 per share for the quarter, up from their prior estimate of $2.52. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $8.99 per share. Zacks Research also issued estimates for Palomar’s Q1 2027 earnings at $2.28 EPS, Q3 2027 earnings at $2.83 EPS, Q4 2027 earnings at $2.70 EPS and FY2028 earnings at $10.62 EPS.

A number of other brokerages have also recently commented on PLMR. Keefe, Bruyette & Woods lowered their target price on Palomar from $186.00 to $159.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th. JPMorgan Chase & Co. reduced their price target on shares of Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 26th. Wall Street Zen cut shares of Palomar from a “buy” rating to a “hold” rating in a report on Sunday, March 1st. Weiss Ratings raised shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday. Finally, Piper Sandler reduced their target price on shares of Palomar from $151.00 to $132.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Palomar currently has an average rating of “Moderate Buy” and an average target price of $147.75.

View Our Latest Stock Analysis on Palomar

Palomar Stock Down 0.1%

Shares of NASDAQ PLMR opened at $111.58 on Tuesday. Palomar has a 52-week low of $100.81 and a 52-week high of $162.65. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. The business’s 50 day moving average is $116.21 and its two-hundred day moving average is $122.38. The firm has a market cap of $2.96 billion, a price-to-earnings ratio of 15.54 and a beta of 0.44.

Palomar (NASDAQ:PLMRGet Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, topping the consensus estimate of $2.17 by $0.14. The firm had revenue of $278.94 million for the quarter, compared to analyst estimates of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The business’s revenue for the quarter was up 59.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.87 EPS.

Insider Transactions at Palomar

In other news, CEO Mac Armstrong sold 3,500 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $114.39, for a total transaction of $400,365.00. Following the completion of the transaction, the chief executive officer directly owned 332,888 shares of the company’s stock, valued at approximately $38,079,058.32. The trade was a 1.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $125.00, for a total transaction of $375,000.00. Following the sale, the president owned 62,919 shares in the company, valued at $7,864,875. The trade was a 4.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 15,134 shares of company stock valued at $1,896,081. Corporate insiders own 3.70% of the company’s stock.

Institutional Investors Weigh In On Palomar

Several institutional investors have recently modified their holdings of PLMR. HighTower Advisors LLC boosted its holdings in shares of Palomar by 652.7% in the fourth quarter. HighTower Advisors LLC now owns 17,613 shares of the company’s stock valued at $2,374,000 after acquiring an additional 15,273 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Palomar by 12.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 88,841 shares of the company’s stock worth $10,372,000 after buying an additional 9,831 shares in the last quarter. Moran Wealth Management LLC acquired a new stake in shares of Palomar in the 4th quarter valued at approximately $2,473,000. Danske Bank A S boosted its stake in shares of Palomar by 69.9% in the fourth quarter. Danske Bank A S now owns 138,295 shares of the company’s stock valued at $18,637,000 after buying an additional 56,898 shares in the last quarter. Finally, Elo Mutual Pension Insurance Co purchased a new position in Palomar in the third quarter worth $1,392,000. 90.25% of the stock is owned by hedge funds and other institutional investors.

Palomar Company Profile

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Further Reading

Earnings History and Estimates for Palomar (NASDAQ:PLMR)

Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.